Terramycin

규격

79-57-2CAS 번호

239-293-7EC 번호

(4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamideIUPAC 명칭

C22H24N2O9화학식

460.4 g/mol분자량

Terramycin; RefChem:932744; Lidocaine hydrochloride; oxytetracycline; (4S,4aR,5S,5aR,6S,12aR)-2-carbamoyl-4-(dimethylazaniumyl)-5,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracen-1-olate; 103-115-5; oxytetracycline; 79-57-2; Oxymycin; Oxitetraciclina; Oxytetracyclin; Oxyterracine; Ryomycin; Biostat; Oxitetracyclin; Terramitsin; Adamycin; Riomitsin; Oxytetracycline (anhydrous); Tetran; Oxitetracyclinum; Oxytetracyclinum; Oxyterracin; Oxytetracycline anhydrous; Terrafungine; 5-Hydroxytetracycline; Oxyterracyne; Solkaciclina; Dabicycline; Fanterrin; Geomycin; Geotilin; Imperacin; Lenocycline; Oksisyklin; Proteroxyna; Ursocyclin; Ursocycline; Oxypam; Tarocyn; Tarosin; Teravit; Antibiotic TM 25; Oxytetracycline amphoteric; Liquamycin LA 200; Biostat PA; Oxytetracycline [INN]; Berkmycen; Oxysteclin; Oxymykoin; Vendarcin; Ossitetraciclina; Pennox 200; Oxy-Kesso-tetra; Oxytetracycline (Terramycin); Stevacin; Mycoshield TMQTHC 20; Bisolvomycin; Dalimycin; Oxacycline; Unimycin; NSC-9169; Macocyn; Medamycin; Oxytetracycline calcium; Biosolvomycin; Mepatar; DTXSID1034260; OTC (antibiotic); (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide; Stecsolin; Oxydon; MLS000069429; NSC 9169; SLF0D9077S; C22H24N2O9; Tetracycline, 5-hydroxy-; Terramycine; Nitox; Oxytetracycline (internal use); MFCD00003700; TM 5; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6S,12aS)-; Oxytetracid; E703; NCI-C56473; SMR000059000; Terramycin im; Terramycin Q50; Oxytetracycline base; Galsenomycin; Oxytetracycline (dihydrate); Ossitetraciclina [DCIT]; 5-Hydroxytetracycline Dihydrate; (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-; OTC; Oxytetracyclinum [INN-Latin]; Oxitetraciclina [INN-Spanish]; Terramicina Oftalmica; Geomycin (Streptomyces vimosus); HSDB 3145; NSC-757262; EINECS 201-212-8; LA 200; BRN 2714587; UNII-SLF0D9077S; Embryostat; SR-01000003006; Hydroxytetracyclinum; Oxytetracycline CRS; 5-Hydroxy-Tetracycline; Spectrum_001055; Opera_ID_661; Oxytetracycline dehydrate; Oxytetracyclinum dihydras; Prestwick0_000307; Prestwick1_000307; Prestwick2_000307; Prestwick3_000307; Spectrum2_000988; Spectrum3_000536; Spectrum4_000466; Spectrum5_001148; Doxycycline EP Impurity E; Oxytetracycline (Standard); SCHEMBL2899; CHEMBL1517; OXYTETRACYCLINE [MI]; BSPBio_000274; BSPBio_002151; DOXYCYCLINE IMPURITY E; KBioGR_000912; KBioSS_001535; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-; 4-14-00-02633 (Beilstein Handbook Reference); DivK1c_000225; SCHEMBL560497; SPBio_001055; SPBio_002493; BPBio1_000302; CHEMBL461529; orb1310191; CHEMBL1401333; CHEMBL4280957; DTXCID9014260; NSC9169 (HCL); OXYTETRACYCLINE [WHO-DD]; SCHEMBL13169109; SCHEMBL13782651; SCHEMBL26627996; SCHEMBL29538576; SCHEMBL29876138; CHEBI:27701; GTPL10919; HY-B0275R; KBio1_000225; KBio2_001535; KBio2_004103; KBio2_006671; KBio3_001651; 6153-64-6 (di-hydrate); MSK4111; NINDS_000225; BDBM241973; DTXSID201370921; GLXC-23416; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4S-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.))-; 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide; 79-57-2 (ANHYDROUS); HY-B0275; 2058-46-0 (mono-hydrochloride); Tox21_302380; EBC-11061; LMPK07000005; s1773; AKOS015951277; AKOS015961254; CCG-269334; DB00595; FO31724; CAS-79-57-2; IDI1_000225; NCGC00091268-04; NCGC00091268-05; NCGC00091268-06; NCGC00091268-07; NCGC00091268-08; NCGC00091268-09; NCGC00091268-10; NCGC00091268-11; NCGC00091268-12; NCGC00091268-18; NCGC00188956-01; NCGC00255168-01; (2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione; AC-12777; AC-13466; PD132319; 7179-50-2 (calcium (1:1) salt); OXYTETRACYCLINE (ANHYDROUS) [HSDB]; SBI-0051473.P003; NS00000179; O9396; Partially skimmed milk powder-Oxytetracycline; ST50307307; SW196796-3; 15251-48-6; Oxytetracycline 100 microg/mL in Acetonitrile; C06624; E75911; Oxytetra Selective Supplement, for microbiology; Oxytetracycline 1000 microg/mL in Acetonitrile; Partially skimmed milk powder - Oxytetracycline; AB00053514_04; AB00053514_05; AB01274728-01; AB01274728_02; 6153-65-7 (di-hydrochloride salt, di-hydrate); Oxytetracycline; Doxycycline Hyclate EP Impurity E; Q411646; DOXYCYCLINE HYCLATE IMPURITY E [EP IMPURITY]; SR-01000003006-5; Q63393012; DOXYCYCLINE MONOHYDRATE IMPURITY E [EP IMPURITY]; Z1515385075; Oxytetracycline, British Pharmacopoeia (BP) Reference Standard; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide; (4S,4AR,5S,5AR,6S,12AS)-4-(DIMETHYLAMINO)-3,5,6,10,12,12AHEXAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE; (4S,5S,6S,12aS,4aR,5aR)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide; oxypam; macocyn; adamycin; (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide동의어